Back to search

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Data up to Jan 2025

Published2007
Citations1,820
References32

Total Citations Per Year

Abstract

References (32)

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1999 • 8,737 citations

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

2003 • 6,072 citations

The causal relation between human papillomavirus and cervical cancer

2002 • 3,451 citations

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

2002 • 3,068 citations

Human papillomavirus and cervical cancer

2007 • 2,789 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

2007 • 2,003 citations

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

2005 • 1,551 citations

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

2003 • 1,535 citations

Epidemiology of Genital Human Papillomavirus Infection

1997 • 1,122 citations

Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality

2003 • 818 citations

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

2006 • 803 citations

Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention

2006 • 656 citations

Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

2006 • 480 citations

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

2002 • 465 citations

A Population-Based Study of Squamous Cell Vaginal Cancer: HPV and Cofactors

2002 • 333 citations

Partial characterization of viral DNA from human genital warts (condylomata acuminata)

1980 • 279 citations

Vulvar Intraepithelial Neoplasia

2005 • 261 citations

An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).

2001 • 249 citations

Trends in Squamous Cell Carcinoma of the Vulva: The Influence of Vulvar Intraepithelial Neoplasia

1997 • 232 citations

Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women.

2000 • 228 citations

Genital Human Papillomavirus Infection in Men

2007 • 196 citations

Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England

2001 • 179 citations

Management of anogenital warts (condylomata acuminata).

2001 • 108 citations

Exact power and sample size for vaccine efficacy studies

1998 • 81 citations

PATHOGENESIS AND TREATMENT OF JUVENILE ONSET RECURRENT RESPIRATORY PAPILLOMATOSIS

2000 • 62 citations

RECURRENT RESPIRATORY PAPILLOMATOSIS OF THE LARYNX

2000 • 51 citations

Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach

2001 • 48 citations

Primary Vaginal Cancer

1998 • 31 citations

The rationale for prophylactic cancer vaccines and need for a paradigm shift

2006 • 16 citations

Detection of human papillomavirus type 16 in bowenoid papulosis and nonbowenoid tissues

2003 • 12 citations

JUVENILE LARYNGEAL PAPILLOMATOSIS IN A PEDIATRIC POPULATION: A Clinicopathologic Study

1997 • 11 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases (2007) – New England Journal of Medicine | Metascience Observatory Explorer